US11045469B2 - Compositions and Methods for Treating Inflammatory Bowel Disease Using a Combination Therapy of Small Molecule Inhibitors of C-C Chemokine Receptor Type 9 (CCR9) and Anti-Α4β7 Integrin Blocking Antibodies